Genomic landscape of Epstein–Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue

[1]  E. Sokol,et al.  Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients , 2020, Nature Communications.

[2]  A. Harrod,et al.  The role of the SWI/SNF chromatin remodelling complex in the response to DNA double strand breaks. , 2020, DNA repair.

[3]  Ryan D. Morin,et al.  TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate , 2020, Cell.

[4]  M. Seifert,et al.  Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted Sequencing , 2020, Cancers.

[5]  A. Tzankov,et al.  High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B‐cell lymphomas , 2020, Hematological oncology.

[6]  R. Gascoyne,et al.  Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses , 2019, Haematologica.

[7]  L. Rimsza,et al.  Enhanced DNA repair and genomic stability identify a novel HIV‐related diffuse large B‐cell lymphoma signature , 2019, International journal of cancer.

[8]  Lauren C. Chong,et al.  Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. , 2019, Blood.

[9]  J. Viola,et al.  IRF2BP2: A new player in the regulation of cell homeostasis , 2019, Journal of leukocyte biology.

[10]  Jian-xin Lin,et al.  Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses , 2019, Proceedings of the National Academy of Sciences.

[11]  E. Robertson,et al.  Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus , 2019, Journal of Virology.

[12]  C. Jefferies.  Regulating IRFs in IFN Driven Disease , 2019, Front. Immunol..

[13]  T. Kanai,et al.  Methotrexate-associated Lymphoproliferative Disorder of the Stomach Presumed to Be Mucosa-associated Lymphoid Tissue Lymphoma , 2018, Internal medicine.

[14]  A. Rosenwald,et al.  Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma. , 2018, The Journal of investigative dermatology.

[15]  E. Jaffe,et al.  Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings , 2018, The American journal of surgical pathology.

[16]  W. Park,et al.  Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement , 2018, Modern Pathology.

[17]  G. Vassiliou,et al.  Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites , 2018, Haematologica.

[18]  M. Kool,et al.  A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models , 2018, Front. Immunol..

[19]  B. Scheijen,et al.  Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma , 2017, Journal of Hematopathology.

[20]  A. Rickinson,et al.  Epstein–Barr virus-associated lymphomas , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.

[21]  K. Naresh,et al.  Mutational landscape of B‐cell post‐transplant lymphoproliferative disorders , 2017, British journal of haematology.

[22]  Y. Natkunam,et al.  B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report—Part 2 , 2017, American journal of clinical pathology.

[23]  J. Choi,et al.  The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP , 2017, Oncotarget.

[24]  J. Bailey,et al.  Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type–Specific Differences , 2017, Molecular Cancer Research.

[25]  W. Klapper,et al.  Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas , 2016, Oncotarget.

[26]  M. Du.  MALT lymphoma: A paradigm of NF-κB dysregulation. , 2016, Seminars in cancer biology.

[27]  V. Jobanputra,et al.  The genetic landscape of dural marginal zone lymphomas , 2016, Oncotarget.

[28]  D. Bonney,et al.  Successful Curative Therapy With Rituximab and Allogeneic Haematopoietic Stem Cell Transplantation for MALT Lymphoma Associated With STK4‐Mutated CD4+ Lymphocytopenia , 2016, Pediatric blood & cancer.

[29]  S. Tomlins,et al.  Comprehensive Genomic Profiling of Orbital and Ocular Adnexal Lymphomas Identifies Frequent Alterations in MYD88 and Chromatin Modifiers: New Routes to Targeted Therapies , 2016, Modern Pathology.

[30]  Ryan D. Morin,et al.  Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas , 2015, Clinical Cancer Research.

[31]  P. Ng,et al.  SIFT missense predictions for genomes , 2015, Nature Protocols.

[32]  Yongwook Choi,et al.  PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels , 2015, Bioinform..

[33]  J. Downs,et al.  The SWI/SNF chromatin remodelling complex: Its role in maintaining genome stability and preventing tumourigenesis. , 2015, DNA repair.

[34]  E. Lenkiewicz,et al.  Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer , 2015, Oncotarget.

[35]  S. Ogawa,et al.  Genome-Wide Analysis of Ocular Adnexal Lymphoproliferative Disorders Using High-Resolution Single Nucleotide Polymorphism Array. , 2015, Investigative ophthalmology & visual science.

[36]  J. Bennett,et al.  Epstein-barr virus-associated extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma) arising in the parotid gland of a child with ataxia telangiectasia. , 2015, Journal of pediatric hematology/oncology.

[37]  A. Attygalle,et al.  Helicobacter pylori infection in gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma: a re-evaluation , 2014, Gut.

[38]  Lars Feuk,et al.  The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..

[39]  M. Ozdemirli,et al.  EBV‐positive low‐grade marginal zone lymphoma in the breast with massive amyloid deposition arising in a heart transplant patient: A report of an unusual case , 2013, Pediatric transplantation.

[40]  Sander R. Dubovy,et al.  Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas , 2013, American journal of hematology.

[41]  P. Van Loo,et al.  Gene Expression Profiling Reveals Clear Differences Between EBV‐Positive and EBV‐Negative Posttransplant Lymphoproliferative Disorders , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[42]  M. Du,et al.  Distinct involvement of NF‐κB regulators by somatic mutation in ocular adnexal malt lymphoma , 2013, British journal of haematology.

[43]  Dereje D. Jima,et al.  The genetic landscape of mutations in Burkitt lymphoma , 2012, Nature Genetics.

[44]  Xiong-zeng Zhu,et al.  A20 inactivation in ocular adnexal MALT lymphoma , 2012, Haematologica.

[45]  I. Lossos,et al.  Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities , 2012, Modern Pathology.

[46]  C. Park,et al.  Thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a clinicopathological and genetic analysis of six cases , 2011, Leukemia & lymphoma.

[47]  J. Akey.  Analysis of 2,440 human exomes highlights the evolution and functional impact of rare coding variation , 2011, Genome Biology.

[48]  R. Gascoyne,et al.  Genomic profiles of MALT lymphomas: variability across anatomical sites , 2011, Haematologica.

[49]  U. Surti,et al.  EBV-Positive Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue in the Posttransplant Setting: A Distinct Type of Posttransplant Lymphoproliferative Disorder? , 2011, The American journal of surgical pathology.

[50]  Francesco Bertoni,et al.  Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. , 2011, Blood.

[51]  Y. Tamaki,et al.  Epstein-Barr Virus-Related Atypical Lymphoproliferative Disorders in Waldeyer’s Ring: A Clinicopathological Study of 9 Cases , 2010, Pathobiology.

[52]  Y. Yatabe,et al.  Coexistence of primary pulmonary Hodgkin lymphoma and gastric MALT lymphoma associated with Epstein‐Barr virus infection: A case report , 2010, Pathology international.

[53]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[54]  J. Radford,et al.  A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma , 2010, Leukemia.

[55]  Francesco Bertoni,et al.  Genome wide DNA‐profiling of HIV‐related B‐cell lymphomas , 2010, British journal of haematology.

[56]  E. Hsi,et al.  Extramedullary plasmacytoma-like posttransplantation lymphoproliferative disorders: clinical and pathologic features. , 2009, American journal of clinical pathology.

[57]  S. Ogawa,et al.  Frequent inactivation of A20 in B-cell lymphomas , 2009, Nature.

[58]  R. Dalla‐Favera,et al.  Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma , 2009, Nature.

[59]  H. Müller-Hermelink,et al.  A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation‐negative MALT lymphoma of the ocular adnexa and salivary glands , 2009, The Journal of pathology.

[60]  L. Pasqualucci,et al.  The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. , 2008, Blood.

[61]  S. Tsuzuki,et al.  TNFAIP3 is the target gene of chromosome band 6q23.3‐q24.1 loss in ocular adnexal marginal zone B cell lymphoma , 2008, Genes, chromosomes & cancer.

[62]  N. Shinton.  WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .

[63]  H. Tagawa,et al.  Genome‐wide array‐based comparative genomic hybridization of ocular marginal zone B cell lymphoma: Comparison with pulmonary and nodal marginal zone B cell lymphoma , 2007, Genes, chromosomes & cancer.

[64]  R. Siebert,et al.  The pattern of genomic gains in salivary gland MALT lymphomas. , 2007, Haematologica.

[65]  R. Siebert,et al.  Distinct comparative genomic hybridisation profiles in gastric mucosa‐associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21) , 2006, British journal of haematology.

[66]  D. Barford,et al.  Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF , 2004, Cell.

[67]  H. S. Kim,et al.  BRAF mutations in non-Hodgkin's lymphoma , 2003, British Journal of Cancer.

[68]  P. Galieni,et al.  Typical genomic imbalances in primary MALT lymphoma of the orbit , 2003, The Journal of pathology.

[69]  S. Pittaluga,et al.  Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization , 1997, Leukemia.

[70]  Marilyn M. Li,et al.  Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. , 2017, The Journal of molecular diagnostics : JMD.

[71]  F. Vega,et al.  Epstein-Barr Virus-Positive Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue in the Posttransplant Setting: An Immunodeficiency-Related (Posttransplant) Lymphoproliferative Disorder? , 2017, American journal of clinical pathology.

[72]  K. Karube,et al.  Mutation analysis of NF-κB signal pathway-related genes in ocular MALT lymphoma. , 2012, International journal of clinical and experimental pathology.

[73]  M. Negrini,et al.  Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases. , 2001, Haematologica.

[74]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.